This study suggests that the combination of IL-6, CRP, and cortisol can be an excellent indicator to differentiate MDD with or without anhedonia, which might help clinicians identify patients with MDD with anhedonia early, thus developing more appropriate treatment strategies to achieve better outcomes. The gene discussed is CRP; the disease is major depressive disorder.